GLP-1 Receptor Agonists Yes, it may sound odd to use a drug known for managing type 2 diabetes and obesity to treat migraines, but the medication may also address the inflammatory roots of migraine
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
20 , e550 (2019)
Flj produktens anvisningar och brja lgt vid knslig mage
Proanthocyanidins, ()-epigallocatechin-3-gallate, and dihydromyricetin, representative flavanols (Figure 7A), have been shown to exert neuroprotective effects by inhibiting ferroptosis (Table 4)
After 12 months, this therapy resulted in weight improvement, with a weight loss of 10 kg and a BMI reduction from 30 to 26.4 kg/m, and better glycemic control, as demonstrated by a reduction in HbA1c levels (7.4%)